Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neo-CRAG: Neoadjuvant Chemoradiotherapy vs Chemotherapy in Gastric Cancer
NCT01815853Phase 3Completed
- Sponsor
- Sun Yat-sen University
- Start
- Jun 2013
- Primary completion
- Jun 2025
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin, capecitabine in gastric cancer (GC), sponsored by Sun Yat-sen University. Started Jun 2013; status: completed.
02
Drugs
oxaliplatincapecitabine
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01815853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01815853.